HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Giovannini Selected Research

Thrombocytopenia (Thrombopenia)

1/2011Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program.
4/2009The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Giovannini Research Topics

Disease

50Neoplasms (Cancer)
11/2023 - 10/2002
24Neurofibromatosis 2 (Neurofibromatosis Type II)
06/2024 - 08/2002
20Neurilemmoma (Schwannoma)
06/2024 - 08/2002
10Carcinogenesis
11/2016 - 06/2003
8Meningioma (Meningiomas)
01/2023 - 07/2007
8Pain (Aches)
01/2016 - 01/2004
7Neurofibromatoses (Neurofibromatosis)
11/2023 - 04/2003
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 05/2011
6Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2023 - 01/2004
6Schwannomatosis
11/2023 - 03/2013
6Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2018 - 12/2013
5Acoustic Neuroma (Acoustic Neurinoma)
02/2024 - 06/2009
4Neoplasm Metastasis (Metastasis)
11/2020 - 05/2003
4Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2017 - 01/2014
4Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 10/2009
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2015 - 07/2013
4Mesothelioma
02/2011 - 04/2003
3Leukemia
01/2023 - 04/2009
3Glioma (Gliomas)
01/2018 - 07/2007
3Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013 - 06/2008
3Neurofibrosarcoma (MPNST)
01/2013 - 06/2009
3Renal Insufficiency (Renal Failure)
06/2012 - 06/2010
3Malignant Mesothelioma
02/2011 - 04/2003
3Mucositis
10/2009 - 08/2006
2Cancer Pain
01/2016 - 09/2011
2Hemolytic Anemia
05/2014 - 10/2008
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
07/2012 - 07/2009
2Chronic Kidney Failure (Chronic Renal Failure)
05/2011 - 05/2011
2Hemorrhage
01/2011 - 03/2009
2Thrombocytopenia (Thrombopenia)
01/2011 - 04/2009
2Multiple Myeloma
03/2010 - 04/2009
2Stomatitis
10/2009 - 01/2004
2Nervous System Neoplasms (Neoplasms, Nervous System)
07/2007 - 08/2002
2Ascites
12/2005 - 06/2003
1Rare Diseases (Rare Disease)
11/2023
1Osteosarcoma (Osteogenic Sarcoma)
11/2020
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Musculoskeletal Abnormalities
01/2018
1Legius syndrome
01/2018
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
10/2017
1Neuroblastoma
06/2017
1Sarcoma (Soft Tissue Sarcoma)
06/2017
1Ulcer
01/2017
1Inflammation (Inflammations)
11/2016

Drug/Important Bio-Agent (IBA)

29Neurofibromin 2 (Merlin)IBA
01/2023 - 08/2002
8Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2007
7Analgesics (Analgesic Drugs)IBA
01/2016 - 01/2004
6Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2002
6Rituximab (Mabthera)FDA Link
03/2016 - 10/2008
5Azacitidine (5 Azacytidine)FDA Link
01/2023 - 01/2014
4EverolimusFDA Link
02/2024 - 04/2015
4Mechanistic Target of Rapamycin Complex 1IBA
02/2024 - 04/2014
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 05/2008
4Opioid Analgesics (Opioids)IBA
01/2016 - 08/2006
3Uvitex SWN (SWN)IBA
01/2022 - 06/2017
3DecitabineFDA Link
01/2018 - 01/2017
3eltrombopagFDA Link
03/2016 - 03/2014
3AsbestosIBA
02/2011 - 06/2003
2Sirolimus (Rapamycin)FDA Link
01/2023 - 04/2014
2IntegrinsIBA
11/2020 - 08/2011
2Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 01/2018
2TOR Serine-Threonine KinasesIBA
04/2015 - 04/2014
2romiplostimFDA Link
10/2014 - 03/2014
2moesinIBA
12/2011 - 08/2011
2ezrinIBA
12/2011 - 08/2011
2radixinIBA
12/2011 - 08/2011
2Oxycodone (Oxycontin)FDA LinkGeneric
06/2010 - 09/2007
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2008 - 12/2005
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2007 - 01/2007
1LigandsIBA
01/2023
1vistusertibIBA
01/2023
1venetoclaxIBA
01/2023
1Mechanistic Target of Rapamycin Complex 2IBA
01/2023
1Integrin alpha4beta1 (VLA-4)IBA
11/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2019
1Messenger RNA (mRNA)IBA
11/2019
1Adenosine Triphosphate (ATP)IBA
11/2019
1Caspase 9IBA
11/2019
1Caspase 3 (Caspase-3)IBA
11/2019
1Staphylococcal Protein A (Protein A)IBA
11/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2019
1trametinibIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Syk KinaseIBA
01/2018
1nilotinibFDA Link
10/2017
1Bevacizumab (Avastin)FDA Link
10/2017
1Lapatinib (GW572016)FDA Link
10/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016

Therapy/Procedure

22Therapeutics
06/2024 - 10/2002
3Aftercare (After-Treatment)
10/2017 - 01/2006
3Radiotherapy
10/2017 - 09/2009
3Salvage Therapy
01/2017 - 06/2008
3Pain Management
06/2012 - 08/2006
2Palliative Care (Palliative Therapy)
01/2014 - 03/2009
2Drug Therapy (Chemotherapy)
03/2013 - 10/2009
2Transplantation
01/2013 - 01/2004
2Hematopoietic Stem Cell Transplantation
01/2013 - 10/2009
2Stem Cell Transplantation
03/2009 - 09/2007
1Intravenous Injections
11/2020